Investor Overview

Investors

Additional Resources

Shareholder Tools

Print Page
Email Page
Email Alerts
RSS Feeds
Financial Tear Sheet

NASDAQ: XBIT0.002.80Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News

Date	Title
09/20/18	XBiotech Announces Addition of Top Dermatologist and Researcher Dr. Alice Gottlieb to its Team
09/13/18	XBiotech Announces Completion and Positive Interim Findings for Initial Cohort in Bermekimab Pilot Study in Atopic Dermatitis
09/12/18	XBiotech Announces Addition of World Leading Cardiologist Dr. Peter Libby to its Scientific Advisory Board

Upcoming Events

There are currently no events scheduled.